osemozotan has been researched along with atomoxetine hydrochloride in 1 studies
| Studies (osemozotan) | Trials (osemozotan) | Recent Studies (post-2010) (osemozotan) | Studies (atomoxetine hydrochloride) | Trials (atomoxetine hydrochloride) | Recent Studies (post-2010) (atomoxetine hydrochloride) |
|---|---|---|---|---|---|
| 32 | 0 | 4 | 1,386 | 306 | 788 |
| Protein | Taxonomy | osemozotan (IC50) | atomoxetine hydrochloride (IC50) |
|---|---|---|---|
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Baba, A; Hashimoto, H; Köves, K; Kubo, M; Kuroda, M; Shibasaki, Y; Shintani, N; Tsuchida, R | 1 |
1 other study(ies) available for osemozotan and atomoxetine hydrochloride
| Article | Year |
|---|---|
An antihyperkinetic action by the serotonin 1A-receptor agonist osemozotan co-administered with psychostimulants or the non-stimulant atomoxetine in mice.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Central Nervous System Stimulants; Dioxanes; Dioxoles; Dose-Response Relationship, Drug; Drug Interactions; Hyperkinesis; Male; Methamphetamine; Mice; Mice, Inbred ICR; Piperazines; Propylamines; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2009 |